Long COVID with high IL-6, CRP and ESR: improved on Actemra for a year, then relapsed
- Condition
- Long COVID
- At worst
- Not stated
- Ill before improving or writing
- Not stated
- Last post
- Mar 2026
In their words
- Condition: Long COVID
I have high IL-6 and high CRP & ESR
In context ↗ - Now: Relapsed
did well on Actemra for a year then all the symptomatic benefit went away
In context ↗
Read from 1 of their posts and comments; links to the one this page draws on
Summary
A Reddit user on a long-COVID forum reported high IL-6 together with high CRP and ESR, and said they had done well on Actemra for a year. After that year, all the symptomatic benefit went away, so the improvement from the drug did not last, and their inflammatory markers were still high when they wrote.
Ask Miruvor AI
What they tried
What they credit
Their words about each treatment
- Actemra · Helped
did well on Actemra for a year then all the symptomatic benefit went away
In context ↗
Approaches: Biologics & antibodies
Their path
They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.
| When | What happened |
|---|---|
| — | ill with raised IL-6, CRP and ESRI have high IL-6 and high CRP & ESRIn context ↗ |
| — | did well on Actemradid well on Actemra for a yearIn context ↗ |
| 2026-03-06 | symptomatic benefit of Actemra wore offthen all the symptomatic benefit went awayIn context ↗ |
Ask Miruvor AI
Similar stories
-
ME/CFS with PEM after a virus, much better on low-dose naltrexone and tocilizumab
They fell ill at 23 after an upper respiratory virus they never recovered from, with PEM, chronic migraine, dysautonomia, MCAS and unrefreshing sleep. Low-dose naltrexone shortened their PEM and raised their energy; a later diagnosis of Yao syndrome, an…